A detailed history of Ubs Group Ag transactions in Kazia Therapeutics LTD stock. As of the latest transaction made, Ubs Group Ag holds 23,336 shares of KZIA stock, worth $148,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,336
Holding current value
$148,416
% of portfolio
0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.2 - $0.46 $4,667 - $10,734
23,336 New
23,336 $5,000
Q4 2023

Feb 09, 2024

BUY
$0.39 - $0.99 $39 - $99
100 New
100 $0
Q4 2022

Feb 08, 2023

BUY
$0.5 - $1.23 $1,248 - $3,070
2,496 Added 64.71%
6,353 $3,000
Q3 2022

Nov 10, 2022

BUY
$1.1 - $4.19 $1,525 - $5,811
1,387 Added 56.15%
3,857 $4,000
Q2 2022

Aug 10, 2022

BUY
$4.1 - $8.38 $10,127 - $20,698
2,470 New
2,470 $10,000
Q1 2022

May 16, 2022

SELL
$6.05 - $8.65 $18,452 - $26,382
-3,050 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$7.35 - $12.0 $19,440 - $31,740
2,645 Added 653.09%
3,050 $26,000
Q3 2021

Nov 15, 2021

BUY
$8.65 - $11.64 $3,503 - $4,714
405 New
405 $5,000
Q2 2021

Aug 13, 2021

SELL
$9.1 - $14.71 $14,705 - $23,771
-1,616 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$8.98 - $12.86 $11,090 - $15,882
-1,235 Reduced 43.32%
1,616 $20,000
Q4 2020

Feb 11, 2021

BUY
$5.61 - $13.47 $8,583 - $20,609
1,530 Added 115.82%
2,851 $25,000
Q3 2020

Nov 12, 2020

BUY
$3.33 - $8.26 $4,065 - $10,085
1,221 Added 1221.0%
1,321 $9,000
Q2 2020

Jul 31, 2020

SELL
$2.56 - $3.6 $21,911 - $30,812
-8,559 Reduced 98.85%
100 $0
Q1 2020

May 01, 2020

BUY
$2.72 - $4.64 $19,401 - $33,097
7,133 Added 467.43%
8,659 $25,000
Q4 2019

Feb 14, 2020

BUY
$2.84 - $7.4 $4,049 - $10,552
1,426 Added 1426.0%
1,526 $6,000
Q3 2019

Nov 14, 2019

SELL
$2.33 - $3.83 $1,551 - $2,550
-666 Reduced 86.95%
100 $0
Q2 2019

Aug 14, 2019

SELL
$2.31 - $3.58 $1,801 - $2,792
-780 Reduced 50.45%
766 $2,000
Q1 2019

May 14, 2019

SELL
$2.27 - $3.9 $5,556 - $9,547
-2,448 Reduced 61.29%
1,546 $5,000
Q4 2018

Feb 14, 2019

SELL
$2.2 - $3.18 $4,543 - $6,566
-2,065 Reduced 34.08%
3,994 $9,000
Q3 2018

Nov 14, 2018

SELL
$3.05 - $3.9 $1,171 - $1,497
-384 Reduced 5.96%
6,059 $20,000
Q2 2018

Aug 14, 2018

BUY
$2.9 - $5.9 $15,900 - $32,349
5,483 Added 571.15%
6,443 $19,000
Q1 2018

May 15, 2018

SELL
$2.88 - $6.25 $6,027 - $13,081
-2,093 Reduced 68.56%
960 $5,000
Q4 2017

Feb 14, 2018

BUY
$2.4 - $3.41 $7,327 - $10,410
3,053
3,053 $10,000

Others Institutions Holding KZIA

About KAZIA THERAPEUTICS LTD


  • Ticker KZIA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,111,300
  • Market Cap $96.1M
  • Description
  • Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...
More about KZIA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.